By designating just one reference outlined drug as the standard to which all generic variations should be demonstrated being bioequivalent, FDA hopes to stay away from attainable sizeable variations among the generic drugs as well as their brand name counterpart. Occasionally it is not Protected to make use of particular medicines simultaneously